Parkinsonism
52
11
15
20
Key Insights
Highlights
Success Rate
91% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
3.8%
2 terminated out of 52 trials
90.9%
+4.4% vs benchmark
13%
7 trials in Phase 3/4
10%
2 of 20 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 20 completed trials
Clinical Trials (52)
Studies of the Variable Phenotypic Presentations of Rapid-Onset Dystonia Parkinsonism and Other Movement Disorders
A Multimodal Prospective Cohort Study of Parkinsonism
Etiology-Phenotype-Outcome Pathway Study on Freezing of Gait (FOG)
DaTSCAN Imaging in Aging and Neurodegenerative Disease
The Effect of Functional Rotational Exercises on Fall Risk and Mobility in Parkinson's Disease Patients
Clinical Efficacy of Intermittent Theta Burst Transcranial Magnetic Stimulation With Different Modes on Parkinson's Disease
The Effect of Spinal Cord Stimulation on Orthostatic Hypotension in Parkinsonism and Its Related Mechanisms
Observational Case Series of Patients With Parkinson's Disease (PD) Attending a Complementary Medicine Neuro-degenerative Disease (NDD) Clinic.
Proactive and Integrated Management and Empowerment in Parkinson's Disease (PRIME-UK): A New Model of Care (PRIME-RCT)
Saliva and Extracellular Vesicles for Neurodegenerative Diseases
TRANSPARK_LONG: The Diagnostic Value of Early Transcranial Ultrasound in Patients With Extrapyramidal Diseases in a Swedish Population
MIBG in Aging and Neurologic Disorders
Misfolded Proteins in the Skin of People With Parkinson's Disease and Other Parkinsonism
Spinal Cord Stimulation for Parkinsonism
Non-motor Symptoms and Brain Dopamine Transporter Binding
Study of UB-312 in Healthy Participants and Parkinson's Disease Patients
Trial of Parkinson's And Zoledronic Acid
West Sweden Parkinson Objective Measurement Registry Study
Effects of Music Beat on Motor Function in Individuals At Risk for Psychotic Onset and Schizophrenia Patients
Biomarkers in Parkinsonian Syndromes